Table 1. Patients characteristics according to gender.
| Patient characteristics | M | F | p-value |
|---|---|---|---|
| N | 15,708 | 13,094 | |
| % | 54.5 | 45.5 | |
| Age (yrs) | 44.5±16.0 | 45.0±17.0 | 0.17 |
| BMI (Kg/m2) | 25.0±3.7 | 24.2±4.3 | <0.0001 |
| Smokers (%) | 31.8 | 22.7 | <0.0001 |
| Diabetes duration (yrs) | 18.3±13.0 | 18.8±13.0 | 0.0004 |
| Diabetes duration classes (%) | |||
| ≤2 | 10.7 | 9.5 | 0.0006 |
| 2–5 | 8.9 | 8.4 | |
| 5–10 | 14.3 | 13.7 | |
| 10–20 | 26.3 | 27.2 | |
| >20 | 39.8 | 41.2 | |
| HbA1c (%) | 8.0±1.5 | 8.2±1.5 | <0.0001 |
| HbA1c (mmol/mol) | 63.9±16.4 | 66.1±16.4 | <0.0001 |
| Total cholesterol (mg/dl) | 184±36 | 192±35 | <0.0001 |
| HDL cholesterol (mg/dl) | 57±15 | 67±16 | <0.0001 |
| LDL cholesterol (mg/dl) | 108±30 | 108±29 | 0.70 |
| Triglycerides (mg/dl) | 97±89 | 83±56 | <0.0001 |
| Systolic blood pressure (mmHg) | 128±17 | 124±18 | <0.0001 |
| Diastolic blood pressure (mmHg) | 76±9 | 73±9 | <0.0001 |
| Diabetes treatment (%) | |||
| Continuous subcutaneous insulin infusion (CSII) | 13.9 | 19.6 | <0.0001 |
| Multiple daily injection (MDI) | 86.1 | 80.4 | |
| Lipid-lowering agents (%) | 25.4 | 23.5 | 0.0002 |
| Antihypertensive treatment (%) | 28.7 | 26.1 | <0.0001 |